US Attorney Announces Charges Against Two Executives Tied to Philidor Pharmacy Scheme

Thursday, November 17, 2016 | Business of Medicine , Corporate Lawsuits , Personnel/Company News , Valeant NJ

The US Attorney’s Office, Southern District of New York has charged two executives in connection with the Philidor Pharmacy scheme that instigated a stock value plunge at Valeant when it was revealed last year. The US Attorney’s office will hold  a press conference today to formally announce charges against Gary Tanner, a former executive at Valeant Pharmaceuticals International, Inc., and Andrew Davenport, the former Chief Executive Officer of Philidor Rx Services LLC, for engaging in a multi-million dollar fraud and kickback scheme.   

Next Story


You must be logged in to leave a comment.